Study of the Hepatitis C Virus in the Republic of Macedonia

1. World Health Organization (WHO). Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J Viral Hepat. 2001; 6:35-47.10.1046/j.1365-2893.1999.6120139.xSearch in Google Scholar

2. Seeff LB. Natural history of viral hepatitis, type C. Semin Gastrointest Dis. 1995; 6(1): 20-27.Search in Google Scholar

3. Di Bisceglie AM. Hepatitis C and hepatocellular carcinoma Semin Liver Dis. 1995; 15(1): 64-69.Search in Google Scholar

4. Kuo G, Choo QL, Alter HJ, et al. An assay for circulating antibodies to a major etiologic virus of human non- A, non-B hepatitis. Science. 1989; 244(4902): 362-364.10.1126/science.2496467Search in Google Scholar

5. Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med. 2001; 345(1): 41-52.10.1056/NEJM200107053450107Search in Google Scholar

6. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 1989; 244(4902): 359-362.10.1126/science.2523562Search in Google Scholar

7. Houghton M. Hepatitis C virus, In: Fields BN, Knipe DM, Howley PM, Chanock RH, Eds. Fields Virology, 3rd ed. Philadelphia: Lippincott-Raven. 1996: 1035-1058.Search in Google Scholar

8. Al-Faleh F, Ramia S. Hepatitis C virus infection in Saudi Arabia: a review. Ann Saudi Med. 1997; 17(1): 77-82.10.5144/0256-4947.1997.77Search in Google Scholar

9. Bhattacherjee V, Prescott LE, Pike I, et al. Use of NS-4 peptides to identify type-specific antibody to genotypes 1, 2, 3, 4, 5 and 6. J Gen Virol. 1995; 76(Pt 7): 1737-1748.10.1099/0022-1317-76-7-1737Search in Google Scholar

10. McOmish F, Yap PL, Dow BC, et al. Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey. J Clin Microbiol. 1994; 32(4): 884-892.010.1128/jcm.32.4.884-892.1994Search in Google Scholar

11. Mondelli MU, Silini E. Significance of hepatitis C virus genotypes. Viral Hepat Rev. 1995; 1(Suppl 1): 111-120.Search in Google Scholar

12. Silini E, Bono F, Cividini A, et al. Molecular epidemiology of hepatitis C virus infection among intravenous drug users. J Hepatol. 1995; 22(6): 691-695.10.1016/0168-8278(95)80225-8Search in Google Scholar

13. Abdulkarim AS, Zein NN, Germer JJ, et al. Hepatitis C virus genotypes and hepatitis G virus in hemodialysis patients from Syria: identification of two novel hepatitis C virus subtypes. Am J Trop Med Hyg. 1998; 59(4): 571-576.10.4269/ajtmh.1998.59.5719790432Search in Google Scholar

14. Chamberlain RW, Adams N, Saeed AA, Simmonds P, Elliot RM. Complete nucleotide sequence of a type 4 hepatitis C virus variant, the predominant genotype in the Middle East. J Gen Virol. 1994; 78(Pt 6):1341-1347.10.1099/0022-1317-78-6-13419191927Search in Google Scholar

15. Simmonds P, Holmes EC, Cha TA, et al. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol. 1993; 74(Pt 11): 2391-2399.10.1099/0022-1317-74-11-23918245854Search in Google Scholar

16. Cha TA, Kolberg J, Irvine B, et al. Use of a signature nucleotide sequence of hepatitis C virus for detection of viral RNA in human serum and plasma. J Clin Microbiol. 1992; 29(11): 2528-2534.10.1128/jcm.29.11.2528-2534.19912703671663510Search in Google Scholar

17. Tokita HS, Shrestha M, Okamoto H, et al. Hepatitis C virus variants from Nepal with novel genotypes and their classification into the third major group. J Gen Virol. 1994; 75(Pt 4): 931-936.10.1099/0022-1317-75-4-9318151307Search in Google Scholar

18. Tokita HH, Okamoto H, Iizuka H, et al. Hepatitis C virus variants from Jakarta, Indonesia classifiable into novel genotypes in the second (2e and 2f), tenth (10a) and eleventh (11a) genetic groups. J Gen Virol. 1996; 77(Pt 2): 293-301.10.1099/0022-1317-77-2-2938627233Search in Google Scholar

19. Tokita HH, Okamoto H, Iizuka J, Kishimoto F, Tsuda Y, Mayumi M. The entire nucleotide sequences of three hepatitis C virus isolates in genetic groups 7-9 and comparison with those in the other eight genetic groups. J Gen Virol. 1998; 79(Pt 8): 1847-1857.10.1099/0022-1317-79-8-18479714232Search in Google Scholar

20. Kiprijanovska S. Prevalence and genotyping of HCV infection in patients belonging to different risk groups in the Republic of Macedonia. Prilozi. 2012; (submitted)Search in Google Scholar

21. Simjanovska LJ, Porcu K, Amitov V, Efremov GD, Polenakovic M. Reverse transcriptase/polymerase chain reaction analysis of hemodialysis ultrafiltrates and sera of hepatitis C virus positive patients. Int J Artif Organs. 2004; 27(1): 35-39.10.1177/03913988040270010814984182Search in Google Scholar

22. Popovski Z, Dimovski A, Simjanovska L, et al. Molecular detection and characterization of hepatitis C virus in the Republic of Macedonia. Makedonski medicinski pregled. 1996; 50(4):85-90.Search in Google Scholar

23. Kiprijanovska S, Noveski P, Chalovska V, Polenakovic M, Plaseska-Karanfilska D. Association of OASL gene with chronic HCV therapy response to pegylated interferon-a and ribavirin. Proceedings of the 39th European Society for Artificial Organs Congress, Rostock, Germany, 26-29 September 2012; (submitted).Search in Google Scholar